What is it about?
Provides a new chemical scaffold a lead compound for the treatment of HCC.
Featured Image
Why is it important?
HCC is one of the leading cancer, and currently no effective medication is available.
Perspectives
Toward the optimization as a drug candidate for clinical testing.
Prof. Yijun Chen
China Pharmaceutical University
Read the Original
This page is a summary of: Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells, Scientific Reports, July 2018, Springer Science + Business Media,
DOI: 10.1038/s41598-018-29199-8.
You can read the full text:
Contributors
The following have contributed to this page
